{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T10:39:20Z","timestamp":1769164760281,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,1,14]],"date-time":"2010-01-14T00:00:00Z","timestamp":1263427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s00408-009-9226-7","type":"journal-article","created":{"date-parts":[[2010,1,13]],"date-time":"2010-01-13T00:40:22Z","timestamp":1263343222000},"page":"143-149","source":"Crossref","is-referenced-by-count":43,"title":["Undifferentiated Connective Tissue Disease-Associated Interstitial Lung Disease: Changes in Lung Function"],"prefix":"10.1007","volume":"188","author":[{"given":"Brent W.","family":"Kinder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrus","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold R.","family":"Collard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura L.","family":"Koth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Wolters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Golden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph J.","family":"Panos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Talmadge E.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,1,14]]},"reference":[{"issue":"2","key":"9226_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00005792-200203000-00004","volume":"81","author":"C Ferri","year":"2002","unstructured":"Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G et al (2002) Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 81(2):139\u2013153","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"9226_CR2","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1164\/ajrccm.164.7.2103110","volume":"164","author":"WW Douglas","year":"2001","unstructured":"Douglas WW, Tazelaar HD, Hartman TE, Hartman RP, Decker PA, Schroeder DR et al (2001) Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 164(7):1182\u20131185","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"9226_CR3","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/art.21322","volume":"53","author":"SV Kocheril","year":"2005","unstructured":"Kocheril SV, Appleton BE, Somers EC, Kazerooni EA, Flaherty KR, Martinez FJ et al (2005) Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia. Arthritis Rheum 53(4):549\u2013557","journal-title":"Arthritis Rheum"},{"issue":"6","key":"9226_CR4","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/rheumatology\/41.6.676","volume":"41","author":"R Hubbard","year":"2002","unstructured":"Hubbard R, Venn A (2002) The impact of coexisting connective tissue disease on survival in patients with fibrosing alveolitis. Rheumatology (Oxford) 41(6):676\u2013679","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"9226_CR5","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1164\/rccm.200607-912OC","volume":"175","author":"JH Park","year":"2007","unstructured":"Park JH, Kim DS, Park IN, Jang SJ, Kitaichi M, Nicholson AG et al (2007) Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 175(7):705\u2013711","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"9226_CR6","first-page":"313","volume":"21","author":"E Bodolay","year":"2003","unstructured":"Bodolay E, Csiki Z, Szekanecz Z, Ben T, Kiss E, Zeher M et al (2003) Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clin Exp Rheumatol 21(3):313\u2013320","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"9226_CR7","first-page":"816","volume":"26","author":"HJ Williams","year":"1999","unstructured":"Williams HJ, Alarcon GS, Joks R, Steen VD, Bulpitt K, Clegg DO et al (1999) Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10\u00a0years: disease remissions and changes in diagnoses in well established and undifferentiated CTD. J Rheumatol 26(4):816\u2013825","journal-title":"J Rheumatol"},{"issue":"3","key":"9226_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/BF01451046","volume":"17","author":"MG Danieli","year":"1998","unstructured":"Danieli MG, Fraticelli P, Salvi A, Gabrielli A, Danieli G (1998) Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD. Clin Rheumatol 17(3):195\u2013201","journal-title":"Clin Rheumatol"},{"issue":"2","key":"9226_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1191\/096120398678919787","volume":"7","author":"M Mosca","year":"1998","unstructured":"Mosca M, Tavoni A, Neri R, Bencivelli W, Bombardieri S (1998) Undifferentiated connective tissue diseases: the clinical and serological profiles of 91 patients followed for at least 1\u00a0year. Lupus 7(2):95\u2013100","journal-title":"Lupus"},{"issue":"9","key":"9226_CR10","first-page":"1340","volume":"18","author":"DO Clegg","year":"1991","unstructured":"Clegg DO, Williams HJ, Singer JZ, Steen VD, Schlegel S, Ziminski C et al (1991) Early undifferentiated connective tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases. J Rheumatol 18(9):1340\u20131343","journal-title":"J Rheumatol"},{"issue":"1","key":"9226_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.autrev.2006.03.004","volume":"6","author":"M Mosca","year":"2006","unstructured":"Mosca M, Tani C, Neri C, Baldini C, Bombardieri S (2006) Undifferentiated connective tissue diseases (UCTD). Autoimmun Rev 6(1):1\u20134","journal-title":"Autoimmun Rev"},{"issue":"5","key":"9226_CR12","first-page":"615","volume":"17","author":"M Mosca","year":"1999","unstructured":"Mosca M, Neri R, Bombardieri S (1999) Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol 17(5):615\u2013620","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"9226_CR13","first-page":"213","volume":"32","author":"A Doria","year":"2005","unstructured":"Doria A, Mosca M, Gambari PF, Bombardieri S (2005) Defining unclassifiable connective tissue diseases: incomplete, undifferentiated, or both? J Rheumatol 32(2):213\u2013215","journal-title":"J Rheumatol"},{"issue":"7","key":"9226_CR14","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1164\/rccm.200702-220OC","volume":"176","author":"BW Kinder","year":"2007","unstructured":"Kinder BW, Collard HR, Koth L, Daikh DI, Wolters PJ, Elicker B et al (2007) Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med 176(7):691\u2013697","journal-title":"Am J Respir Crit Care Med"},{"key":"9226_CR15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1164\/ajrccm.157.1.9704130","volume":"157","author":"JA Bjoraker","year":"1998","unstructured":"Bjoraker JA, Ryu JH, Edwin MK, Myers JL, Tazelaar HD, Schroeder DR et al (1998) Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 157:199\u2013203","journal-title":"Am J Respir Crit Care Med"},{"key":"9226_CR16","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1164\/ajrccm.162.6.2003049","volume":"162","author":"AG Nicholson","year":"2000","unstructured":"Nicholson AG, Colby TV, Dubois RM, Hansell DM, Wells AU (2000) The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 162:2213\u20132217","journal-title":"Am J Respir Crit Care Med"},{"key":"9226_CR17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","volume":"165","author":"American Thoracic Society\/European Respiratory Society","year":"2002","unstructured":"American Thoracic Society\/European Respiratory Society (2002) International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165:277\u2013304","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"9226_CR18","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1164\/rccm.2111053","volume":"167","author":"AU Wells","year":"2003","unstructured":"Wells AU, Desai SR, Rubens MB, Goh NS, Cramer D, Nicholson AG et al (2003) Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med 167(7):962\u2013969","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"9226_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1378\/chest.127.1.171","volume":"127","author":"TE King Jr","year":"2005","unstructured":"King TE Jr, Safrin S, Starko KM, Brown KK, Noble PW, Raghu G et al (2005) Analyses of efficacy end points in a controlled trial of interferon-{gamma}1b for idiopathic pulmonary fibrosis. Chest 127(1):171\u2013177","journal-title":"Chest"},{"issue":"12","key":"9226_CR20","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1164\/rccm.200611-1685OC","volume":"177","author":"WD Travis","year":"2008","unstructured":"Travis WD, Hunninghake G, King TE Jr, Lynch DA, Colby TV, Galvin JR et al (2008) Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med 177(12):1338\u20131347","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"9226_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1183\/09031936.02.00182002","volume":"19","author":"KR Flaherty","year":"2002","unstructured":"Flaherty KR, Toews GB, Travis WD, Colby TV, Kazerooni EA, Gross BH et al (2002) Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J 19(2):275\u2013283","journal-title":"Eur Respir J"},{"issue":"12 Pt 1","key":"9226_CR22","doi-asserted-by":"crossref","first-page":"963","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00005","volume":"142","author":"FJ Martinez","year":"2005","unstructured":"Martinez FJ, Safrin S, Weycker D, Starko KM, Bradford WZ, King TE Jr et al (2005) The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 142(12 Pt 1):963\u2013967","journal-title":"Ann Intern Med"},{"issue":"1","key":"9226_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1164\/rccm.200705-732OC","volume":"177","author":"TE King Jr","year":"2008","unstructured":"King TE Jr, Behr J, Brown KK, du Bois RM, Lancaster L, de Andrade JA et al (2008) BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 177(1):75\u201381","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"9226_CR24","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","volume":"174","author":"RP Baughman","year":"2006","unstructured":"Baughman RP, Drent M, Kavuru M, Judson MA, Costabel U, du Bois R et al (2006) Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 174(7):795\u2013802","journal-title":"Am J Respir Crit Care Med"},{"issue":"25","key":"9226_CR25","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1056\/NEJMoa055120","volume":"354","author":"DP Tashkin","year":"2006","unstructured":"Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE et al (2006) Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 354(25):2655\u20132666","journal-title":"N Engl J Med"},{"issue":"12","key":"9226_CR26","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1002\/art.22204","volume":"54","author":"RK Hoyles","year":"2006","unstructured":"Hoyles RK, Ellis RW, Wellsbury J, Lees B, Newlands P, Goh NS et al (2006) A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis Rheum 54(12):3962\u20133970","journal-title":"Arthritis Rheum"},{"key":"9226_CR27","doi-asserted-by":"crossref","unstructured":"DuBois R, Albera C, Bradford WZ, Costabel U, Hormel P, King Jr TE et al (2009) Predictors of mortality in patients with idiopathic pulmonary fibrosis. In: American Thoracic Society international conference, San Diego, California","DOI":"10.1164\/ajrccm-conference.2009.179.1_MeetingAbstracts.A1114"},{"issue":"4","key":"9226_CR28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2165\/00003495-200464040-00005","volume":"64","author":"M Selman","year":"2004","unstructured":"Selman M, Thannickal VJ, Pardo A, Zisman DA, Martinez FJ, Lynch JP 3rd (2004) Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches. Drugs 64(4):405\u2013430","journal-title":"Drugs"},{"issue":"8","key":"9226_CR29","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1517\/14656566.5.8.1671","volume":"5","author":"VJ Thannickal","year":"2004","unstructured":"Thannickal VJ, Flaherty KR, Martinez FJ, Lynch JP 3rd (2004) Idiopathic pulmonary fibrosis: emerging concepts on pharmacotherapy. Expert Opin Pharmacother 5(8):1671\u20131686","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"9226_CR30","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.ccm.2004.08.003","volume":"25","author":"KK Brown","year":"2004","unstructured":"Brown KK, Raghu G (2004) Medical treatment for pulmonary fibrosis: current trends, concepts, and prospects. Clin Chest Med 25(4):759\u2013772 vii","journal-title":"Clin Chest Med"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-009-9226-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-009-9226-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00408-009-9226-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-009-9226-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T19:30:07Z","timestamp":1581967807000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-009-9226-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,14]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["9226"],"URL":"https:\/\/doi.org\/10.1007\/s00408-009-9226-7","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,14]]}}}